A New Strategy for Elimination of Human Paplloma Virus-related Disease after Human Papillomavirus Vaccines Introduction
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Human papillomavirus (HPV) infections are the most common sexually transmitted diseases in male and female. The most common HPV types include HPV 6/11/16/18/31/33/45/52/58. Bivalent (bHPV), quadrivalent (qHPV), and nonavalent (nHPV) vaccines, have been developed worldwide to protect against HPV infections. This paper describes the worldwide trends in HPV infections after HPV vaccination and shows the progressive changes in national HPV vaccination programs toward gender-neutral vaccination (GNV). This review article is based on original and review articles on the HPV-associated disease burden and nationwide vaccination trends. In Korea, epidemiology studies have shown a decline in the incidence of cervical cancer from 16.3% (in 1999) to 9.1% (in 2015). Interestingly, based on the 2019 annual report from Korean Center for Disease Control, the incidence of anogenital warts increased in both sexes during 2014-2018 and was 2.6 times higher in male than female in 2018. These results indicate the good efficacy of HPV vaccinations against both diseases in female. Other studies suggest that GNV would almost eliminate the risks of HPV-associated diseases in most countries, compared to female-only vaccination. HPV vaccine coverage remains lower in male in Korea despite the vaccine efficacy in both sexes and the worldwide GNV trend. Scaling up HPV vaccination in both sexes should be encouraged. Furthermore, removing the HPV-attributable burden through nHPV vaccination could be considered, showing that HPV 31, 33, 45, 52, 58, which are not covered by bHPV and qHPV, are as prevalent as HPV 6, 11, 16, 18.
Abstract
Human papillomavirus (HPV) infections are the most common sexually transmitted diseases in male and female. The most common HPV types include HPV 6/11/16/18/31/33/45/52/58. Bivalent (bHPV), quadrivalent (qHPV), and nonavalent (nHPV) vaccines, have been developed worldwide to protect against HPV infections. This paper describes the worldwide trends in HPV infections after HPV vaccination and shows the progressive changes in national HPV vaccination programs toward gender-neutral vaccination (GNV). This review article is based on original and review articles on the HPV-associated disease burden and nationwide vaccination trends. In Korea, epidemiology studies have shown a decline in the incidence of cervical cancer from 16.3% (in 1999) to 9.1% (in 2015). Interestingly, based on the 2019 annual report from Korean Center for Disease Control, the incidence of anogenital warts increased in both sexes during 2014-2018 and was 2.6 times higher in male than female in 2018. These results indicate the good efficacy of HPV vaccinations against both diseases in female. Other studies suggest that GNV would almost eliminate the risks of HPV-associated diseases in most countries, compared to female-only vaccination. HPV vaccine coverage remains lower in male in Korea despite the vaccine efficacy in both sexes and the worldwide GNV trend. Scaling up HPV vaccination in both sexes should be encouraged. Furthermore, removing the HPV-attributable burden through nHPV vaccination could be considered, showing that HPV 31, 33, 45, 52, 58, which are not covered by bHPV and qHPV, are as prevalent as HPV 6, 11, 16, 18.
참고문헌 (44)
- Schiffman M, "Human papillomavirus and cervical cancer", Lancet, 370, pp.890~907 (2007)
- Bodily J, "Persistence of human papillomavirus infection : keys to malignant progression", Trends Microbiol, 19, pp.33~39 (2011)
- Herrero R, "Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study", J Natl Cancer Inst, 95, pp.1772~1783 (2003)
- Takla A, "Background paper for the recommendation of HPV vaccination for boys in Germany", Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 61, pp.1170~1186 (2018)
- "Statement on HPV vaccination" (2018)[URL]
- Brisson M, "Population-level impact, herd immunity, and elimination after human papillomavirus vaccination : a systematic review and meta-analysis of predictions from transmission-dynamic models", Lancet Public Health, 1, pp.e8~e17 (2016)
- Korostil IA, "Near elimination of genital warts in Australia predicted with extension of human papillomavirus vaccination to males", Sex Transm Dis, 40, pp.833~835 (2013)
- Park YJ, "Annual prevalence and economic burden of genital warts in Korea : Health Insurance Review and Assessment(HIRA)service data from 2007 to 2015", Epidemiol Infect, 146, pp.177~186 (2018)
- Oh EJ, "Sexually transmitted infections (STIs) surveillance in the Republic of Korea, 2014-2018", Public Health Wkly Rep, 13, pp.911~921 (2020)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
- 나은희, "Human Papillomavirus Genotype Distribution Among 18,815 Women in 13 Korean Cities and Relationship With Cervical Cytology Findings", Annals of Laboratory Medicine, 37(5), pp.426~433 (2017), 대한진단검사의학회
- Bosch FX, "Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia", Vaccine, 26(Suppl 10), pp.K1~K16 (2008)
- Kreimer AR, "Human papillomavirus types in head and neck squamous cell carcinomas worldwide : a systematic review", Cancer Epidemiol Biomarkers Prev, 14, pp.467~475 (2005)
- De Vuyst H, "Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus : a meta-analysis", Int J Cancer, 124, pp.1626~1636 (2009)
- 이은희, "Prevalence and Distribution of Human Papillomavirus Infection in Korean Women as Determined by Restriction Fragment Mass Polymorphism Assay", Journal of Korean Medical Science, 27(9), pp.1091~1097 (2012), 대한의학회
- Quek SC, "Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia", Int J Gynecol Cancer, 23, pp.148~156 (2013)
- 박성진, "Prevalence and Determinants of High-Risk Human Papillomavirus Infection in Male Genital Warts", Investigative and Clinical Urology, 55(3), pp.207~212 (2014), 대한비뇨의학회
- Shin HR, "Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea", J Infect Dis, 190, pp.468~476 (2004)
- Stratton KL, "A contemporary review of HPV and penile cancer", Oncology(Williston Park), 30, pp.245~249 (2016)
- Rubin MA, "Detection and typing of human papillomavirus DNA in penile carcinoma : evidence for multiple independent pathways of penile carcinogenesis", Am J Pathol, 159, pp.1211~1218 (2001)
- Maden C, "History of circumcision, medical conditions, and sexual activity and risk of penile cancer", J Natl Cancer Inst, 85, pp.19~24 (1993)
- Dunne EF, "Prevalence of HPV infection among men : a systematic review of the literature", J Infect Dis, 194, pp.1044~1057 (2006)
- Giuliano AR, "The optimal anatomic sites for sampling heterosexual men for human papillomavirus(HPV)detection : the HPV detection in men study", J Infect Dis, 196, pp.1146~1152 (2007)
- Baldwin SB, "Human papillomavirus infection in men attending a sexually transmitted disease clinic", J Infect Dis, 187, pp.1064~1070 (2003)
- Svare EI, "Risk factors for genital HPV DNA in men resemble those found in women : a study of male attendees at a Danish STD clinic", Sex Transm Infect, 78, pp.215~218 (2002)
- Lazcano-Ponce E, "High prevalence of human papillomavirus infection in Mexican males : comparative study of penile-urethral swabs and urine samples", Sex Transm Dis, 28, pp.277~280 (2001)
- Giuliano AR, "The human papillomavirus infection in men study : human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States", Cancer Epidemiol Biomarkers Prev, 17, pp.2036~2043 (2008)
- Miralles-Guri C, "Human papillomavirus prevalence and type distribution in penile carcinoma", J Clin Pathol, 62, pp.870~878 (2009)
- Arbyn M, "Worldwide burden of cervical cancer in 2008", Ann Oncol, 22, pp.2675~2686 (2011)
- 권순석, "Updates on cancer epidemiology in Korea, 2018", 전남의대학술지, 54(2), pp.90~100 (2018), 의과학연구소[DOI]
- Remmerbach TW, "PCR detection of human papillomavirus of the mucosa : comparison between MY09", 11 and GP5+, J Clin Virol, pp.2004, 30[DOI]
- Bae, Jeong-Hoon, "Human Papillomavirus (HPV) Type Distribution in Korean Women: A Meta-Analysis", Journal of Microbiology and Biotechnology, 18(4), pp.788~794 (2008), 한국미생물·생명공학회
- Patel EU, "Increases in human papillomavirus vaccination among adolescent and young adult males in the United States, 2011-2016", J Infect Dis, 218, pp.109~113 (2018)
- "NCI-designated cancer centers endorse goal of eliminating HPV-related cancers" (2018)[URL]
- 오영택, "Prevalence of human papillomavirus genotypes and precancerous cervical lesions in a screening population in the Republic of Korea, 2014–2016", Journal of Gynecologic Oncology, 29(1), pp.1~10 (2018), 대한부인종양학회[DOI]
- Hintze JM, "Strengthening the case for gender-neutral and the nonavalent HPV vaccine", Eur Arch Otorhinolaryngol, 275, pp.857~865 (2018)
- Machalek DA, "Very low prevalence of vaccine human papillomavirus types among 18-to 35-year old Australian women 9 years following implementation of vaccination", J Infect Dis, 217, pp.1590~1600 (2018)
- Garland SM, "Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program", Vaccine, 36, pp.3221~3230 (2018)
- Dillner J, "Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs", Vaccine, 36, pp.3820~3829 (2018)
- Wheeler CM, "The impact of quadrivalent human papillomavirus(HPV; types 6, 11, 16, and 18)L1virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years", J Infect Dis, 199, pp.936~944 (2009)
- Harder T, "Efficacy, effectiveness and safety of vaccination against human papillomavirus in males : a systematic review", BMC Med, 16, pp.110~ (2018)
- Giuliano AR, "Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males", N Engl J Med, 364, pp.401~411 (2011)
- Oh CM, "Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009", PLoS One, 8, pp.e72012~ (2013)
- Korean sexually transmitted infection guidelines 2016, "Korea Centers for Disease Control and Prevention", Korea Centers for Disease Control and Prevention, ~ (2016)